BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22736137)

  • 1. [Comparison of targeting distribution of two kinds of fluorouracil magnetic albumin microspheres in colorectal neoplasm nude mice in vivo under magnetic field].
    Liu ZC; Liu JG; Kong X; Jiang T; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jun; 15(6):622-4. PubMed ID: 22736137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assam Bora rice starch based biocompatible mucoadhesive microsphere for targeted delivery of 5-fluorouracil in colorectal cancer.
    Ahmad MZ; Akhter S; Anwar M; Ahmad FJ
    Mol Pharm; 2012 Nov; 9(11):2986-94. PubMed ID: 22994847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics and distribution of 5-Fu magnetic albumin deuto-microsphere in normal and tumor-bearing mice].
    Xu R; Shi SJ; Zhou SC; Zheng JW; Chen H; Zou SQ; Zeng FD
    Yao Xue Xue Bao; 2007 Jan; 42(1):66-70. PubMed ID: 17520810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits.
    Pohlen U; Reszka R; Schneider P; Buhr HJ; Berger G
    Anticancer Res; 2004; 24(3a):1699-704. PubMed ID: 15274343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effect of angiogenesis inhibitor YH-16 in combination with 5-FU on liver metastasis of colorectal cancer].
    Zhou ZW; Wan DS; Wang GQ; Ren JQ; Lu ZH; Tang SX; Ye YL; Chen G; Lin SX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):161-4. PubMed ID: 16555161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice.
    Hao X; Cheng G; Zou M; Sun J; Cui F
    Pharmazie; 2004 Sep; 59(9):709-12. PubMed ID: 15497754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats.
    Ganguly K; Kulkarni AR; Aminabhavi TM
    Drug Deliv; 2016 Oct; 23(8):2838-2851. PubMed ID: 26530807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-aortal therapy with 5-fluorouracil- polyethylene glycol stealth liposomes: does the metabolism of 5-fluorouracil into 5-fluoro-2'-deoxyuridine depend on ph value?. An animal study in VX-2 liver tumor-bearing rabbits.
    Pohlen U; Binnenhei M; Reszka R; Buhr HJ; Berger G
    Chemotherapy; 2004 Jun; 50(2):67-75. PubMed ID: 15211080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of combination of low dosage 131I-labeled anti-carcinoembryonic antigen antibody C50 and 5-fluorouracil on tumor growth of colorectal cancer xenografts in nude mice].
    Zheng CX; Zhan WH; Cai SR; He YL; Lin ZJ
    Ai Zheng; 2003 Apr; 22(4):354-7. PubMed ID: 12703987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional injection of 5-fluorouracil and starch microspheres in colorectal cancer.
    Ball AS; Mann CV; Clifton MA; Baker WN; Goode AW
    Acta Chir Scand; 1988 Sep; 154(9):521-4. PubMed ID: 3201864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of simultaneous intraportal administration of 5-fluorouracil, uracil and degradable starch microspheres on experimental hepatic micrometastasis, is of colon cancer.
    Nakasaki H; Hanaue H; Yasuda S; Fujii K; Tajima T; Mitomi T; Kurosawa T
    Tokai J Exp Clin Med; 1994 Sep; 19(1-2):83-91. PubMed ID: 7660389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles.
    Stutchbury TK; Vine KL; Locke JM; Chrisp JS; Bremner JB; Clingan PR; Ranson M
    Anticancer Drugs; 2011 Jan; 22(1):24-34. PubMed ID: 20881836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEG-liposomal oxaliplatin potentialization of antitumor efficiency in a nude mouse tumor-xenograft model of colorectal carcinoma.
    Yang C; Liu HZ; Lu WD; Fu ZX
    Oncol Rep; 2011 Jun; 25(6):1621-8. PubMed ID: 21455585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
    Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
    Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil.
    Li LH; Dong H; Zhao F; Tang J; Chen X; Ding J; Men HT; Luo WX; Du Y; Ge J; Tan BX; Cao D; Liu JY
    Eur J Cancer; 2013 May; 49(7):1752-60. PubMed ID: 23313143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
    Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G
    Clin Cancer Res; 1999 Dec; 5(12):3948-55. PubMed ID: 10632324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice.
    Jin Y; Li J; Rong LF; Lü XW; Huang Y; Xu SY
    Acta Pharmacol Sin; 2005 Feb; 26(2):250-6. PubMed ID: 15663907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 5-fluorouracil-loaded floating gastroretentive hollow microsphere: development, pharmacokinetic in rabbits, and biodistribution in tumor-bearing mice.
    Huang Y; Wei Y; Yang H; Pi C; Liu H; Ye Y; Zhao L
    Drug Des Devel Ther; 2016; 10():997-1008. PubMed ID: 27042001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cytotoxic effects of the adriamycin magnetic albumin microspheres combined with external magnetic fields on the malignant tumor cells].
    Tao K; Chen D; Tian Y; Wu Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Jun; 18(2):223-6. PubMed ID: 11450539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.